Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.
about
The Potential Role of Kallistatin in the Development of Abdominal Aortic AneurysmElevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signalingProtective and antioxidant effects of PPARα in the ischemic retina.Familial exudative vitreoretinopathy and related retinopathies.Angiogenesis in diabetes and obesityNanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularizationMicroRNA-184 modulates canonical Wnt signaling through the regulation of frizzled-7 expression in the retina with ischemia-induced neovascularization.Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.Regulation of endothelial progenitor cell release by Wnt signaling in bone marrow.Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance.Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19+ B lymphocytes in the peripheral blood.Kallistatin suppresses cancer development by multi-factorial actions.Antagonizing Wnt pathway in diabetic retinopathy.Protective Role of Kallistatin in Vascular and Organ Injury.Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.
P2860
Q26741231-5BE78D19-4B03-4340-B337-A8E6655ADAC0Q33787188-2A005031-4822-4203-B5B2-302C5DCEBC8DQ33943655-5E75158A-2813-493E-B989-1A5E7DEA3294Q34905378-1F9088B9-0F72-4A07-B0DD-16ADB6E384AEQ35153884-0ED40503-1D86-42EB-8C02-20F7FAE5AFE8Q35224472-B023DC5B-670C-435E-9D0C-FE6A31D28CD3Q35528580-3D97C13E-8580-4493-A110-95B314A1389CQ35717941-19A00D6B-5390-4882-87C8-861F59760A68Q37302307-3BC55A7F-F090-432F-9AE8-23FB32DC1E9DQ38838756-CB8CE4B5-B573-4326-B3F6-57F06D14925FQ38904274-28B5DCF1-3279-4BC0-A8DF-8E09614727BCQ39252905-0BA4356B-C33D-4F1A-857D-A61FC397CEFEQ42149497-8AA7721B-257E-4312-B0C4-826FE51F208AQ42360588-C9A84497-2030-44A5-A05B-C818A2CEF6BAQ47247582-23FCB140-38D7-4732-9EBF-884BC2757599
P2860
Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@en
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@nl
type
label
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@en
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@nl
prefLabel
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@en
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@nl
P2093
P2860
P356
P1433
P1476
Antiangiogenic and antineuroin ...... ith the canonical Wnt pathway.
@en
P2093
Jeffrey D McBride
Jian-xing Ma
Kevin Zhou
Kyungwon Lee
Xiaochen Liu
Yueping Zhou
P2860
P304
P356
10.2337/DB12-1710
P407
P577
2013-07-24T00:00:00Z